SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-20-087999
Filing Date
2020-07-29
Accepted
2020-07-29 21:53:55
Documents
5
Effectiveness Date
2020-07-30

Document Format Files

Seq Description Document Type Size
1 S-8 tm2025639d1_s8.htm S-8 54199
2 EXHIBIT 5.1 tm2025639d1_ex5-1.htm EX-5.1 17944
3 EXHIBIT 23.2 tm2025639d1_ex23-2.htm EX-23.2 3000
4 EXHIBIT 99.1 tm2025639d1_ex99-1.htm EX-99.1 93866
5 GRAPHIC tm2025639d1_ex5-1img001.jpg GRAPHIC 4915
  Complete submission text file 0001104659-20-087999.txt   177043
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-240178 | Film No.: 201058961
SIC: 2834 Pharmaceutical Preparations